European Archives - Page 5 of 1431 - European Medical Journal

Novo Nordisk launches higher-dose semaglutide

Novo Nordisk has launched a 7.2 mg semaglutide injection in the US, following FDA approval on 19 March.

Ultra-Processed Foods Linked to Weakness in Dialysis Patients

Higher ultra-processed food intake is linked to increased clinical weakness in hemodialysis patients, new research shows.

AI Model Boosts Lung Cancer Detection Accuracy to 96%

A new hybrid AI model improves lung cancer detection on CT scans, achieving over 96% accuracy for early tumour identification.

Fertility-Inducing Medications May Increase Melanoma Risk

Among infertile women, those treated with fertility-inducing medications face an increased melanoma risk, according to a 2026 systematic review and meta-analysis.

UKKW 2026 Interview: Patrick Mark

Professor of Nephrology, University of Glasgow; Honorary Consultant Nephrologist, The Queen Elizabeth University Hospital, Glasgow, UK…..

ISGE 2026 Interview: Basil C. Tarlatzis

Congresses are important opportunities to connect with researchers, discuss new developments, and share knowledge. This Congress has…..

Editor's Pick: Management of the Neurogenic Bladder: Challenges Across the Lifespan

The term neurogenic bladder is defined as bladder dysfunction resulting from damage to the nerves that control the bladder in the…

Heart Attack Damage Driven by Natural Killer Cells

Genetic deletion or pharmacological depletion of NK cells reduced cardiomyocyte death, limited inflammation, and improved cardiac function.

Binge Drinking Once a Month May Triple Liver Fibrosis Risk

Patients with MASLD who binge drink, even once a month, face a threefold higher risk of advanced liver fibrosis.

ASCVD costs global health industry $680bn annually

Atherosclerotic cardiovascular disease costs the equivalent of Sweden’s entire economy, a new report has revealed.